CLOVER BIO-B (02197) announces mid-term results, with profit attributable to equity holders of the parent company reaching 955 million yuan, turning a profit compared to the previous year.

06:33 26/08/2026

Sanyecao Biotechnology-B (02197) announced its results for the six months ending June 30, 2026. During this period, the group reported revenue of RMB 179,000, a year-on-year decrease of 94.5%; other income and gains amounted to RMB 1.1112 billion, a year-on-year increase of 6200.94%; profit attributable to equity holders of the parent company was RMB 955 million, turning from loss to profit year-on-year; basic earnings per share were RMB 0.75.

CLOVER BIO-B (02197) announced its results for the six months ending June 30, 2026, during which the group generated revenue of 179,000 RMB, a decrease of 94.5% year-on-year; other income and gains amounted to 1.1112 billion RMB, an increase of 6200.94% year-on-year; profit attributable to equity holders of the parent was 955 million RMB, reversing from a loss to a profit; basic earnings per share were 0.75 RMB.

GIORDANO INT'L (00709) announced its interim results, with a profit attributable to shareholders of HKD 108 million, a year-on-year decrease of 10.74%. It plans to distribute an interim dividend of HKD 0.067 per share.

CG SERVICES (06098) announced its interim results, with a profit attributable to shareholders of approximately 950 million yuan, a decrease of 4.6% compared to the same period last year.

GIORDANO INT'L (00709) will distribute a mid-term dividend of HKD 0.067 per share on October 2.

CG SERVICES (06098) announced its interim results, with a profit attributable to shareholders of approximately 950 million yuan, a decrease of 4.6% compared to the same period last year.

GIORDANO INT'L (00709) will distribute a mid-term dividend of HKD 0.067 per share on October 2.